Stratos Wealth Partners, Ltd. Novartis Ag Transaction History

Stratos Wealth Partners, Ltd.

  • $6.9 Billion
  • Q4 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 12,385 shares of NVS stock, worth $1.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,385
Previous 12,449 0.51%
Holding current value
$1.35 Million
Previous $1.43 Million 15.79%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025
SELL
$96.78 - $117.18 $6,193 - $7,499
-64 Reduced 0.51%
12,385 $1.21 Million
Q3 2024

Oct 17, 2024
SELL
$106.13 - $120.89 $95,729 - $109,042
-902 Reduced 6.76%
12,449 $1.43 Million
Q2 2024

Jul 24, 2024
BUY
$92.57 - $107.37 $87,478 - $101,464
945 Added 7.62%
13,351 $1.42 Million
Q1 2024

Apr 16, 2024
SELL
$95.27 - $108.47 $95,936 - $109,229
-1,007 Reduced 7.51%
12,406 $1.2 Million
Q4 2023

Jan 24, 2024
BUY
$92.27 - $101.54 $20,945 - $23,049
227 Added 1.72%
13,413 $1.35 Million
Q3 2023

Oct 24, 2023
BUY
$94.73 - $105.13 $86,109 - $95,563
909 Added 7.4%
13,186 $1.34 Million
Q2 2023

Jul 18, 2023
SELL
$92.52 - $104.91 $59,952 - $67,981
-648 Reduced 5.01%
12,277 $1.24 Million
Q1 2023

Apr 27, 2023
SELL
$80.03 - $92.81 $58,501 - $67,844
-731 Reduced 5.35%
12,925 $1.19 Million
Q4 2022

Jan 19, 2023
BUY
$75.55 - $92.52 $88,997 - $108,988
1,178 Added 9.44%
13,656 $0
Q3 2022

Oct 24, 2022
SELL
$74.61 - $87.26 $59,613 - $69,720
-799 Reduced 6.02%
12,478 $948,000
Q2 2022

Jul 22, 2022
BUY
$80.52 - $93.75 $122,631 - $142,781
1,523 Added 12.96%
13,277 $1.12 Million
Q1 2022

Apr 26, 2022
SELL
$80.11 - $90.62 $14,019 - $15,858
-175 Reduced 1.47%
11,754 $1.03 Million
Q4 2021

Jan 14, 2022
BUY
$79.7 - $88.13 $14,425 - $15,951
181 Added 1.54%
11,929 $1.04 Million
Q3 2021

Oct 19, 2021
BUY
$81.78 - $95.14 $2,616 - $3,044
32 Added 0.27%
11,748 $961,000
Q2 2021

Jul 19, 2021
SELL
$85.24 - $94.15 $84,728 - $93,585
-994 Reduced 7.82%
11,716 $1.07 Million
Q1 2021

Apr 27, 2021
SELL
$83.5 - $98.47 $62,708 - $73,950
-751 Reduced 5.58%
12,710 $1.09 Million
Q4 2020

Jan 29, 2021
SELL
$78.07 - $94.43 $166,835 - $201,796
-2,137 Reduced 13.7%
13,461 $1.27 Million
Q3 2020

Oct 29, 2020
SELL
$82.14 - $91.0 $106,864 - $118,391
-1,301 Reduced 7.7%
15,598 $1.36 Million
Q2 2020

Jul 28, 2020
BUY
$80.93 - $91.1 $367,584 - $413,776
4,542 Added 36.76%
16,899 $1.48 Million
Q1 2020

May 04, 2020
BUY
$70.67 - $99.01 $217,380 - $304,554
3,076 Added 33.14%
12,357 $1.02 Million
Q4 2019

Jan 29, 2020
SELL
$84.35 - $95.37 $59,044 - $66,759
-700 Reduced 7.01%
9,281 $879,000
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $844,194 - $930,251
9,869 Added 8811.61%
9,981 $867,000
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $851,978 - $938,829
-9,960 Reduced 98.89%
112 $1.02 Million
Q2 2019

Aug 06, 2019
SELL
$75.4 - $92.8 $42,148 - $51,875
-559 Reduced 5.26%
10,072 $920,000
Q1 2019

May 07, 2019
BUY
$75.32 - $86.15 $9,415 - $10,768
125 Added 1.19%
10,631 $1.02 Million
Q4 2018

Feb 08, 2019
BUY
$73.66 - $82.02 $32,999 - $36,744
448 Added 4.45%
10,506 $902,000
Q3 2018

Nov 02, 2018
SELL
$66.94 - $77.43 $42,707 - $49,400
-638 Reduced 5.96%
10,058 $867,000
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $1.89 Million - $2.14 Million
-29,193 Reduced 73.19%
10,696 $808,000
Q1 2018

May 10, 2018
BUY
$70.39 - $84.15 $55,960 - $66,899
795 Added 2.03%
39,889 $3.23 Million
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $261,255 - $280,435
-3,612 Reduced 8.46%
39,094 $3.28 Million
Q3 2017

Nov 07, 2017
BUY
$74.14 - $77.27 $3.17 Million - $3.3 Million
42,706
42,706 $3.67 Million

Others Institutions Holding NVS

# of Institutions
1,477
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email